Iluvien is now available in the United States! Finally receiving FDA approval in late 2014, the injectable sustained release intravitreal implant is on the market.
Alimera Sciences states that Iluvien (sustained release of fluocinolone) will release its drug for up to 3 years.
Iluvien Treats Diabetic Macular Edema
Diabetic macular edema is the most common vision threatening complication of diabetic retinopathy. In essence, normal blood vessels (Read more...)